tirzepatide cardiovascular outcomes trial results august 2025 Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of in HFpEF: The SUMMIT Can Dual Incretin Receptor Agonists
Description
[DOI] [PubMed] [Google Scholar] 22.Pharmacology, physiology, and mechanisms of incretin hormone action
Jalleh RJ, Plummer MP, Marathe CS, et al
This does not guarantee safety, but it provides the theoretical foundation for why researchers suspected these medications might be compatible with breastfeeding long before human studies confirmed it
Other Medications and Health Conditions Your overall health and medication list also matter
